Company profile: Univercells
1.1 - Company Overview
Company description
- Provider of end-to-end, high-density, low-cost biomanufacturing solutions, including the NevoLine vaccine platform (incl. inactivated polio vaccine), scale-X single-use bioreactors, Exothera viral vector CDMO, custom bioproduction hubs with preclinical to commercial GMP capabilities, turnkey advisory for local site design/operation/regulatory compliance, and Ntensify RNA production in mobile labs; engineered to cut investments >75% and cost of goods up to 90%.
Products and services
- Exothera: builds a viral-vector-specialized CDMO producing viral vectors for cell and gene therapies, integrating contract development and manufacturing expertise to accelerate advanced therapy bioproduction
- NevoLine™ Platform: architects an end-to-end biomanufacturing system for vaccine production, including inactivated polio vaccine, engineered for affordability and scalability to enable low-cost, high-density vaccine manufacturing
- Scale-X™ Bioreactor: engineers a single-use bioreactor portfolio developed for efficient and scalable biomanufacturing processes, supporting high-density, low-cost manufacturing across antibodies, proteins, and vaccines
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Univercells
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
Amaryllis Nucleics
HQ: United States
Website
- Description: Provider of proprietary RNA sequencing methods and end-to-end solutions delivering shorter turnaround from RNA to library prep and complete data analysis at a lower cost per sample compared to whole transcriptome sequencing approaches for RNASeq; Bay Area-based start-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amaryllis Nucleics company profile →
MateraCor
HQ: United States
Website
- Description: Provider of trans-catheter myocardial restoration (TCMR) therapy comprising an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection fraction (HFrEF), developing novel approaches to prevent progression and reverse heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MateraCor company profile →
OptraScan
HQ: United States
Website
- Description: Provider of digital pathology slide scanners and imaging solutions that convert glass slides into high-resolution images, with integrated software for image management and telepathology. Offerings include high-speed whole slide scanners, compact low-volume and 15-slide brightfield systems, an AI-enabled cytology scanner with real-time analysis, and a frozen section scanner with live remote review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OptraScan company profile →
LabMinds
HQ: United States
Website
- Description: Provider of AI and robotics-driven solution preparation for pharmaceutical and life science labs, offering the accroma bufferPrep System to prepare buffers via customizable recipes, handling up to 26 chemicals with automated water dosing, solids/liquids dosing, stirring, pH adjustment, vacuum filtration, and autoclean/validation, plus cloud-based software for buffer ordering, inventory, secure data storage, and web browser control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LabMinds company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Univercells
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Univercells
2.2 - Growth funds investing in similar companies to Univercells
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Univercells
4.2 - Public trading comparable groups for Univercells
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →